Microvesicles in chronic lymphocytic leukemia: ready for prime time in the clinic?

Sasanka M Handunnetti^{1

2

3}, Aaron Polliack⁴, Constantine S Tam^{1

2

3}

Affiliations

¹ a Haematology Department , Peter MacCallum Cancer Center , Melbourne , Australia.
² b Haematology Department , St Vincent's Hospital , Fitzroy , Australia.
³ c University of Melbourne , Parkville , Australia.
⁴ d Department of Hematology , Hadassah University Hospital and Hebrew University Medical School , Jerusalem , Israel.

Comment

Sasanka M Handunnetti et al. Leuk Lymphoma. 2017 Jun.

. 2017 Jun;58(6):1281-1282.

doi: 10.1080/10428194.2017.1298756.

Sasanka M Handunnetti^{1

2

3}, Aaron Polliack⁴, Constantine S Tam^{1

2

3}

¹ a Haematology Department , Peter MacCallum Cancer Center , Melbourne , Australia.
² b Haematology Department , St Vincent's Hospital , Fitzroy , Australia.
³ c University of Melbourne , Parkville , Australia.
⁴ d Department of Hematology , Hadassah University Hospital and Hebrew University Medical School , Jerusalem , Israel.

No abstract available

Comment on

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ; International Workshop on Chronic Lymphocytic Leukemia. Hallek M, et al. Blood. 2008 Jun 15;111(12):5446-56. doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23. Blood. 2008. PMID: 18216293 Free PMC article.